Clinical features and practical diagnosis of bullous pemphigoid
- PMID: 22560135
- DOI: 10.1016/j.iac.2012.04.002
Clinical features and practical diagnosis of bullous pemphigoid
Abstract
Bullous pemphigoid (BP) represents the most common autoimmune subepidermal blistering disease. BP typically affects the elderly and is associated with significant morbidity. It has usually a chronic course with spontaneous exacerbations. The cutaneous manifestations of BP can be extremely protean. While diagnosis of BP in the bullous stage is straightforward, in the non-bullous stage or in atypical variants of BP signs and symptoms are frequently non-specific with eg, only itchy excoriated, eczematous, papular and/or urticarial lesions that may persist for several weeks or months. Diagnosis of BP critically relies on immunopathologic examinations including direct immunofluorescence microscopy and detection of serum autoantibodies by indirect immunofluorescence microscopy or BP180-ELISA.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Clinical features and practical diagnosis of bullous pemphigoid.Dermatol Clin. 2011 Jul;29(3):427-38, viii-ix. doi: 10.1016/j.det.2011.03.010. Dermatol Clin. 2011. PMID: 21605808 Review.
-
Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.G Ital Dermatol Venereol. 2008 Feb;143(1):1-8. G Ital Dermatol Venereol. 2008. PMID: 18833046 Clinical Trial.
-
Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.Clin Exp Dermatol. 2010 Aug;35(6):614-7. doi: 10.1111/j.1365-2230.2009.03731.x. Epub 2009 Oct 23. Clin Exp Dermatol. 2010. PMID: 19874345
-
Detection of anti-BP180NC16a and anti-BP230 autoantibodies in blister fluid of patients with bullous pemphigoid: the first survey in Greece.Clin Exp Dermatol. 2008 Mar;33(2):183-5. doi: 10.1111/j.1365-2230.2007.02622.x. Epub 2007 Dec 18. Clin Exp Dermatol. 2008. PMID: 18093242
-
Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida.Exp Dermatol. 2013 Jun;22(6):381-5. doi: 10.1111/exd.12146. Epub 2013 May 7. Exp Dermatol. 2013. PMID: 23651418 Review.
Cited by
-
COVID-19 Vaccine: A Potential Risk Factor for Accelerating the Onset of Bullous Pemphigoid.Vaccines (Basel). 2024 Sep 5;12(9):1016. doi: 10.3390/vaccines12091016. Vaccines (Basel). 2024. PMID: 39340046 Free PMC article.
-
New-onset or flare-up of bullous pemphigoid associated with COVID-19 vaccines: a systematic review of case report and case series studies.Front Med (Lausanne). 2024 Apr 8;11:1293920. doi: 10.3389/fmed.2024.1293920. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38654835 Free PMC article.
-
Utility of C3d and C4d immunohistochemical staining in formalin-fixed skin or mucosal biopsy specimens in diagnosis of bullous pemphigoid and mucous membrane pemphigoid.Sci Rep. 2023 Jul 12;13(1):11283. doi: 10.1038/s41598-023-38193-8. Sci Rep. 2023. PMID: 37438374 Free PMC article.
-
Computer-aided classification of indirect immunofluorescence patterns on esophagus and split skin for the detection of autoimmune dermatoses.Front Immunol. 2023 Feb 28;14:1111172. doi: 10.3389/fimmu.2023.1111172. eCollection 2023. Front Immunol. 2023. PMID: 36926325 Free PMC article.
-
Epidermolysis Bullosa Acquisita-Current and Emerging Treatments.J Clin Med. 2023 Feb 1;12(3):1139. doi: 10.3390/jcm12031139. J Clin Med. 2023. PMID: 36769788 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
